Decision to list medical devices supplied by Guerbet Australia Pty Ltd
We are pleased to announce the approval of listing agreements for the supply of medical devices to Health New Zealand | Te Whatu Ora hospitals.
What we’re doing
We are pleased to announce the approval of listing agreements with Guerbet Australia Pty Ltd (“Guerbet”) for the supply of medical devices to Health New Zealand | Te Whatu Ora hospitals in the following category:
In summary this will result in:
- Listing of medical devices in the above category supplied by Guerbet in Part III of Section H of the Pharmaceutical Schedule from 1 May 2023 under a national agreement that all Health New Zealand | Te Whatu Ora hospitals may purchase under (“Agreement”); and
- Health New Zealand | Te Whatu Ora hospitals being able to continue to purchase other suppliers’ brands of medical imaging, software and associated products as the Agreement is not for sole supply.
Any changes to the original proposal?
This decision was subject to a consultation letter dated 15 February 2024.
No changes have been made to the original proposal as a result of the consultation.
Who we think will be most interested
- Health New Zealand | Te Whatu Ora Hospital staff, including but not limited to:
- Clinicians
- Radiology
- Nurses
- Clinical engineers and maintenance services
- Procurement and supply chain personnel
- Suppliers and wholesalers
Details about this decision
In November 2020 Pharmac and NZHP released an RFP:
The RFP was for non-exclusive national agreements for listing on the Pharmaceutical Schedule.
Pharmac has been working with suppliers who responded to the RFP to seek provisional agreements. This proposal consists of the latest agreement to arise from this RFP and we expect to consult on further provisional agreements in the future.
Health New Zealand | Te Whatu Ora hospitals can continue to choose which medical imaging, software and associated products they procure, including those from other suppliers.
Health New Zealand | Te Whatu Ora hospitals that procure medical imaging, software and associated products from Guerbet Australia Pty Ltd must ensure they do so under the terms and conditions, including pricing, in the Agreement from 1 May 2024.
Our response to what you told us
We appreciate the time people took to review this consultation. No feedback was received in relation to this proposal.
If you have any questions about this decision, you can email us at enquiry@pharmac.govt.nz; or call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 66 00 50.